GeneCentric
Durham, United States (US) · Health and Medical
Do your work at GeneCentric?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
Overview
GeneCentric is a Durham, North Carolina-based precision oncology company transforming cancer diagnostics through gene expression analysis.
We specialize in developing innovative liquid biopsy solutions, leveraging our proprietary ExpressCT™ technology and GenomicsNext™ platform.
GenomicsNext™ delivers a comprehensive, single-sample readout of both DNA alterations and inferred gene expression, providing a more complete picture of the tumor’s ‘on state’ and enhancing biomarker discovery and therapy selection.
GeneCentric partners with biopharma, diagnostic developers, and researchers to enable expression-driven companion diagnostics and advance the next generation of precision medicine.
We specialize in developing innovative liquid biopsy solutions, leveraging our proprietary ExpressCT™ technology and GenomicsNext™ platform.
GenomicsNext™ delivers a comprehensive, single-sample readout of both DNA alterations and inferred gene expression, providing a more complete picture of the tumor’s ‘on state’ and enhancing biomarker discovery and therapy selection.
GeneCentric partners with biopharma, diagnostic developers, and researchers to enable expression-driven companion diagnostics and advance the next generation of precision medicine.
Contact Details
+1-919-973-6544
info@genecentric.com
Durham, United States (US), 6 Davis Dr
Founded
2011
Company Type
Private Limited Company
Employees
10-20
Categories
Keywords
#liquid biopsy
#multimodal genomics and gene expression signatures
Companies teams usually look at after GeneCentric
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.